COPD Drugs Lecture PDF Flashcards

1
Q

Most common sources of acute exacerbation of COPD (4)

Single most important etiologic agent in development of COPD

A
  • strep pneumoniae
  • haemophilus influenzae
  • mycoplasma pneumonaie
  • influenza and adenovirus

-Chronic inhalation of tobacco smoke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2 effective drug classes for treatment of COPD

A
  • inhaled B2 adrenergic agonists (short term or long acting)

- short acting antimuscarinic anticholinergic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Advantages of combo therapy of anticholinergics and B2 agonists in treatment of COPD (2)

A
  • rapid onset of action and longer duration

- fewer side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What type of glucocorticoid has been seen to improve and reduce severity of COPD exacerbation?

A

Systemic - prednisone for example

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Antibiotic treatment for COPD exacerbation

A

Based on local resistance patterns and initiated in patients whose sputum characteristics have changed, shown to be effective in decreasing short term mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Examples of antibiotic treatment in COPD (4)

A
  • amoxicillin
  • amoxicillin/clauvonic acid (augmentin)
  • doxycycline (tetracycline)
  • clarithromycin (macrolide)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Varenicline (Chantix) drug class and function

A
  • Centrally acting nicotine receptor antagonist
  • appears most effective agent for smoking cessation in long term treatment of COPD, exacerbations of mental illness with use have been reported
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • Inhaled short acting bronchodilators in COPD patients treatment
  • Inhaled long acting bronchodilators in COPD patients treatment
A
  • Short acting use on regular basis not recommended, used for acute relief
  • Regular lone treatment recommended for patients with moderate to severe dyspnea or increased risk of exacerbations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Inhaled corticosteroids and progression of COPD

A

They do NOT slow progression or reduce mortality of COPD, but improve symptoms less dramatically than in asthmatic patients, not recommended for use alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Theophylline function in COPD

A

Not first line but can be tried in patients with persistent symptoms despite treatment with inhaled triple therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Triple therapy

A

LABA, LAMA, and an inhaled corticosteroid regimen for treatment of COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Rofluminast (Daliresp) durg class and function

A
  • PO phosphodiesterase 4 inhibitor
  • approved to reduce risk of exacerbations in adult patients with severe COPD associated with chronic bronchitis and history of exacerbations, not a bronchodilator
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Rolfumilast (daliresp) ADR’s (2)

A
  • N/V/D

- psychiatric effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Azithromycin drug class and function in COPD

A
  • macrolide antibiotic
  • use once daily can reduce risk of exacerbation over one year and improve quality of life in patients with COPD at increased risk of exacerbation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Antianxiety and antidepressants in COPD treatment DOC and why? What should be avoided?

A
  • Buspirone (Buspar) 5-10mg PO as it does not suppress ventilatory drive, does take SEVERAL weeks to become effective
  • Benzodiazepines should be avoided
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Oxygen therapy for COPD

A

Shown to improve survival and quality of life in patients with COPD and chronic hypoxemia, results best with continuous administration preventing cor pulmonale

17
Q

Treatment guidelines of COPD (GOLD Guidelines)

A

Framework for management based on assessment of symptoms and risk for exacerbation in addition to COPD severity, classified into 1 of 4 additional categories for management from group A (few symptoms, low risk), B (increased symptoms, low risk) C (few symptoms, high risk) and D (increased symptoms, high risk

18
Q

Combivent Respimat

A

A single inhaler combo of SABA with ipratropium that is more effective than either drug alone

19
Q

2 primary goals of COPD management

A
  • reduce symptoms and improve patients health status

- reduce risks and mortality by managing exacerbations